Michael C Heinrich

Michael C Heinrich

UNVERIFIED PROFILE

Are you Michael C Heinrich?   Register this Author

Register author
Michael C Heinrich

Michael C Heinrich

Publications by authors named "Michael C Heinrich"

Are you Michael C Heinrich?   Register this Author

100Publications

3914Reads

26Profile Views

Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases.

Pharmacol Ther 2018 11 30;191:123-134. Epub 2018 Jun 30.

Portland VA Health Care System, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2018.06.016DOI Listing
November 2018

Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases.

Histopathology 2017 Nov 6;71(5):805-812. Epub 2017 Sep 6.

Department of Pathology and Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13292DOI Listing
November 2017

Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance.

Clin Cancer Res 2017 Nov 19;23(21):6733-6743. Epub 2017 Jul 19.

Departments of Medicine and Cell, Developmental, and Cancer Biology, Portland VA Health Care System and OHSU Knight Cancer Institute, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011831PMC
November 2017

Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.

Expert Rev Mol Diagn 2017 May 27;17(5):445-457. Epub 2017 Mar 27.

a Portland VA Health Care System and OHSU Knight Cancer Institute , Portland , OR , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2017.1308826DOI Listing
May 2017

Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to Splitting.

JAMA Oncol 2017 05;3(5):597-599

Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.5740DOI Listing
May 2017

PDGFRA Antibody for Soft Tissue Sarcoma.

Cell 2017 02;168(4):555

Portland VA Health Care System and OHSU Knight Cancer Institute, Portland, OR 97239, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.01.028DOI Listing
February 2017

Management of tyrosine kinase inhibitor-resistant gastrointestinal stromal tumors.

Am Soc Clin Oncol Educ Book 2012 :663-8

From the Division of Hematology and Medical Oncology, Portland VA Medical Center and the Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.663DOI Listing
April 2016

Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update.

Semin Diagn Pathol 2015 Sep 7;32(5):392-9. Epub 2015 Feb 7.

Department of Oncology, Veterans Affairs Portland Heatlh Care System and OHSU Knight Cancer Institute, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semdp.2015.02.017DOI Listing
September 2015

SDHC methylation in gastrointestinal stromal tumors (GIST): a case report.

BMC Med Genet 2015 Sep 28;16:87. Epub 2015 Sep 28.

"Giorgio Prodi" Cancer Research Center, University of Bologna, via Massarenti 11, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12881-015-0233-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587653PMC
September 2015

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.

Cancer Res 2015 Mar 28;75(5):880-91. Epub 2014 Nov 28.

Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348216PMC
March 2015

Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.

Cancer Med 2015 Jan 28;4(1):101-3. Epub 2014 Aug 28.

Department of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; "Giorgio Prodi" Cancer Research Center, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cam4.325
Publisher Site
http://dx.doi.org/10.1002/cam4.325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312123PMC
January 2015

Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity.

Mol Cancer Ther 2014 Dec 24;13(12):2840-51. Epub 2014 Sep 24.

Portland VA Medical Center, Portland, Oregon. OHSU Knight Cancer Institute, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026483PMC
December 2014

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).

BMC Cancer 2014 Sep 20;14:685. Epub 2014 Sep 20.

Department of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181714PMC
September 2014

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

J Clin Oncol 2014 May 17;32(15):1563-70. Epub 2014 Mar 17.

Christopher L. Corless, Violetta Kolesnikova, Charles D. Blanke, Michael C. Heinrich, Oregon Health and Science University, Portland, OR; Karla V. Ballman, Mayo Clinic, Rochester, MN; Cristina R. Antonescu and Ronald P. DeMatteo, Memorial Sloan-Kettering Cancer Center; Robert G. Maki, Mt Sinai School of Medicine, New York, NY; Peter W.T. Pisters and Shreyaskumar Patel, University of Texas MD Anderson Cancer Center, Houston, TX; Martin E. Blackstein, Mount Sinai Hospital, Toronto, Ontario, Canada; George D. Demetri, Dana-Farber Cancer Institute, Boston, MA; Margaret von Mehren, Fox Chase Cancer Institute, Philadelphia, PA; Martin D. McCarter, University of Colorado School of Medicine, Aurora, CO; and Kouros Owzar, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.2046
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026579PMC
May 2014

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.

Clin Cancer Res 2014 Mar 18;20(5):1306-12. Epub 2013 Dec 18.

Authors' Affiliations: Knight Cancer Institute; Department of Public Health and Preventive Medicine; Knight Diagnostic Laboratories, Oregon Health and Science University; Portland VA Medical Center, Portland, Oregon; and Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-1775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947466PMC
March 2014

Regorafenib for treatment of advanced gastrointestinal stromal tumors.

Expert Opin Pharmacother 2014 Mar 10;15(4):549-58. Epub 2014 Jan 10.

Portland VA Medical Center, Oregon Helath & Science University and OHSU Knight Cancer Institute , 3710 SW US Veterans Hospital Rd., Building 103 Lab E223, R&D 19, Portland OR 97239-2999 , USA +1 503 220 3405 ; +1 503 273 5158 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.877888DOI Listing
March 2014

Gastrointestinal stromal tumors: molecular markers and genetic subtypes.

Hematol Oncol Clin North Am 2013 Oct 26;27(5):871-88. Epub 2013 Aug 26.

Hematology and Medical Oncology, Division of Hematology/Oncology, Portland VA Medical Center, OHSU Knight Cancer Institute, Oregon Health & Science University, Mail Code L586, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.07.003DOI Listing
October 2013

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

J Clin Oncol 2013 Sep 17;31(26):3182-90. Epub 2013 Jun 17.

F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute; Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital; Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA; Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR; Philip Friedlander, Mount Sinai Medical Center, New York, NY; Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO; Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Thomas F. Gajewski, University of Chicago, Chicago, IL; Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.7836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878082PMC
September 2013

Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping.

J Mol Diagn 2013 Mar 27;15(2):171-6. Epub 2012 Dec 27.

Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2012.09.003DOI Listing
March 2013

Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.

Cancer Med 2013 Feb 3;2(1):21-31. Epub 2013 Feb 3.

Knight Cancer Institute, Oregon Health and Science University Portland, Oregon ; Division of Hematology and Oncology, Oregon Health and Science University Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797556PMC
February 2013

Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study.

Histopathology 2012 Nov 17;61(5):801-9. Epub 2012 Jul 17.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2012.04300.xDOI Listing
November 2012

Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1.

Am J Hypertens 2012 Oct 12;25(10):1118-23. Epub 2012 Jul 12.

Division of Nephrology, Department of Medicine, Boston Children's Hospital, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajh.2012.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578478PMC
October 2012

Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors.

Mol Cancer Ther 2012 Aug 4;11(8):1770-80. Epub 2012 Jun 4.

Division of Hematology/Oncology, Department of Medicine, Portland VA Medical Center and OHSU Knight Cancer Institute, Oregon Health & Science University, R&D-19 3710 U.S. Veterans Hospital Road, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992122PMC
August 2012

Gastrointestinal stromal tumours: origin and molecular oncology.

Nat Rev Cancer 2011 Nov 17;11(12):865-78. Epub 2011 Nov 17.

Knight Cancer Institute, Division of Haematology & Oncology, and Department of Pathology, Portland VA Medical Center and Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3143DOI Listing
November 2011

The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3β-dependent pathway.

Mol Cancer Ther 2011 Jun 6;10(6):949-59. Epub 2011 Apr 6.

Division of Hematology-Oncology, Gwynne Hazen Cherry Memorial Laboratories, Mattel Children's Hospital UCLA, Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-10
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-10-0904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112478PMC
June 2011

SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.

J Natl Cancer Inst 2011 Jun 19;103(12):983-7. Epub 2011 Apr 19.

Department of Hematology and Oncological Sciences "L.A.Seragnoli," Sant'Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr130DOI Listing
June 2011

"Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.

Am J Surg Pathol 2011 Apr;35(4):495-504

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31820e5f7dDOI Listing
April 2011

Immunohistochemical and molecular markers in breast phyllodes tumors.

Appl Immunohistochem Mol Morphol 2011 Mar;19(2):119-25

Department of Pathology, L471, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e3181f5349aDOI Listing
March 2011

Quantifying Membrane Curvature Generation of Amphiphysin N-BAR Domains.

J Phys Chem Lett 2010 Nov;1(23):3401-3406

University of Pennsylvania, Department of Chemistry.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jz101403qDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679405PMC
November 2010

Imatinib treatment of metastatic GIST: don't stop (believing).

Lancet Oncol 2010 Oct 21;11(10):910-1. Epub 2010 Sep 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(10)70225-4DOI Listing
October 2010

Cancer: Oncogenes in context.

Nature 2010 Oct;467(7317):796-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/467796aDOI Listing
October 2010

Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.

Am J Surg Pathol 2010 Jun;34(6):907-12

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181d9f18fDOI Listing
June 2010

Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.

Breast Cancer Res Treat 2010 Apr 6;120(2):409-18. Epub 2009 May 6.

Department of Pathology, Oregon Health & Science University, L471, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0406-1DOI Listing
April 2010

High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.

Mod Pathol 2010 Jan 6;23(1):27-37. Epub 2009 Nov 6.

Department of Pathology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2009.142DOI Listing
January 2010

Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors.

Clin Cancer Res 2009 Dec;15(24):7510-7518

Authors' Affiliations: Portland VA Medical Center and Oregon Health and Science University Knight Cancer Institute, Portland, Oregon.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-09-0190DOI Listing
December 2009

The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin.

Cell Cycle 2009 Aug 24;8(16):2621-30. Epub 2009 Aug 24.

Medizinische Universitätsklinik, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, Eberhard-Karls-University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cc.8.16.9355
Publisher Site
http://dx.doi.org/10.4161/cc.8.16.9355DOI Listing
August 2009

Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.

Pediatr Blood Cancer 2009 Jul;52(7):767-71

Pediatric Oncology, Dana-Farber Cancer Institute and Department of Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21909DOI Listing
July 2009

RNAi screen for rapid therapeutic target identification in leukemia patients.

Proc Natl Acad Sci U S A 2009 May 11;106(21):8695-700. Epub 2009 May 11.

Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0903233106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680429PMC
May 2009

Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer.

Mol Cancer Ther 2009 Mar 10;8(3):481-9. Epub 2009 Mar 10.

University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmonology, Otfried-Müller-Strasse 10, 72074 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-08-1068DOI Listing
March 2009

Imatinib targeting of KIT-mutant oncoprotein in melanoma.

Clin Cancer Res 2008 Dec;14(23):7726-32

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1144DOI Listing
December 2008

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

J Clin Oncol 2008 Nov 27;26(33):5352-9. Epub 2008 Oct 27.

Division of Hematology/Oncology, Department of Medicine and Cell and Developmental Biology, Portland Veterans Affairs Medical Center and Oregon Health and Science University Cancer Institute, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.7461DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651076PMC
November 2008

KIT gene mutations and copy number in melanoma subtypes.

Clin Cancer Res 2008 Nov;14(21):6821-8

Oregon Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0575DOI Listing
November 2008

Critical exponents for line tension and dipole density difference from lipid monolayer domain boundary fluctuations.

J Phys Chem B 2008 Jul 3;112(27):8063-8. Epub 2008 Jul 3.

Department of Chemistry, Institute for Medicine and Engineering, and Laboratory for Research on the Structure of Matter, University of Pennsylvania, 231 South 34th Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp7116246DOI Listing
July 2008

Molecular pathobiology of gastrointestinal stromal sarcomas.

Annu Rev Pathol 2008 ;3:557-86

Department of Pathology, Oregon Health & Science University Cancer Institute, Portland, OR 97239, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151538DOI Listing
May 2008

Major response to imatinib mesylate in KIT-mutated melanoma.

J Clin Oncol 2008 Apr;26(12):2046-51

The Melanoma Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.0707DOI Listing
April 2008

Primary adenoid cystic carcinoma of the lung: absence of KIT mutations.

Cancer 2007 Dec;110(11):2507-10

Division of Anatomic Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23075DOI Listing
December 2007

BRAF in papillary thyroid carcinoma of ovary (struma ovarii).

Am J Surg Pathol 2007 Sep;31(9):1337-43

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31802f5404DOI Listing
September 2007